FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer

By
Emily Salmini
-
0
7
Researchers evaluated the immunogenicity of Forkhead box protein M1 (FOXM1) and investigated the feasibility of targeting this transcription factor using T-cell receptor (TCR) engineering.
[Cancer Immunology Research]
Full Article